Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinoma - Krug, L M; Miller, V A; Patel, J (Cancer, 2005)
, et al.